Regen Biotech: AestheFill
AestheFill is an FDA-approved, next-generation dermal filler and collagen stimulator based on Poly-D-L-lactic acid (PDLLA) designed for long-term facial rejuvenation. By stimulating natural collagen production over 24-36 months, it restores facial volume, treats deep wrinkles, and improves skin elasticity. It is highly versatile, biodegradable, and effective for sagging skin.
Key Aspects of AestheFill
- Composition: Contains PDLLA (poly D-L-lactic acid), which is highly biocompatible and, unlike traditional fillers, triggers natural neocollagenesis (new collagen formation).
- Mechanism: It works on a cellular level to fill wrinkles and restore structure, often described as having 20 times the water retention capacity of hyaluronic acid.
- Treatment Areas: Primarily used for the face, including cheeks, temples, nasolabial folds, jawline, and neck, but also for skin tightening on the hands, thighs, and abdomen.
- Longevity: Results typically build over 45-90 days and can last for 1.5 to 2 years.
- Vs. Sculptra: AestheFill is considered slightly more versatile due to its ability to be diluted to different concentrations depending on the treatment area.
- Procedure & Care: Often involves minimal downtime, with some practitioners noting it as painless. Post-treatment care requires avoiding extreme temperatures, alcohol, and strenuous exercise for 2 days.
Key Considerations
- Contraindications: Not recommended during pregnancy/breastfeeding, for those with active skin infections, or with a tendency for keloid scarring.
- Professional Application: Should only be administered by trained doctors or cosmetologists.
AestheFill is often used to treat sagging, fine lines, and acne scars, providing a, natural-looking, and, long-lasting anti-aging solution.